Agios supports Investigator Sponsored Trials (ISTs), which are independent, investigator-initiated research designed to advance scientific knowledge of disease states, patient populations and medical treatment in alignment with our clinical and nonclinical areas of interest.
Resources for healthcare providers
We are committed to partnering with all clinical practitioners — doctors, nurses, administration, clinical researchers — who support and treat people with genetically defined disease.
We focus on building trusted relationships with these extended teammates, each of whom lends mission-critical insight enabling better understanding and care for patients.
We aim to further their efforts through providing educational resources, diagnostic tools, grant opportunities and research collaborations.
For medical information queries, please contact us:
Monday – Friday
8:00am – 6:00pm CT
Report an adverse event or product complaint anytime.
A no-cost genetic test may help reveal the cause of your patient’s hereditary anemia. To help physicians reach a diagnosis for their patients, Agios, in partnership with PerkinElmer Genomics, is sponsoring no-cost genetic testing program for patients with suspected hereditary anemias. Visit the site to request a test kit. (U.S. health professionals only)
MyAgios Patient Support Program
Agios offers a patient support program to help those with PK deficiency navigate the challenges of living with the disease and provide support for accessing medicine. Refer patients and their caregivers to enroll in the program to enable customized engagements with a Patient Support Manager. (U.S. residents only)
Independent Medical Education Grants
Agios supports grants for independent medical education to advance knowledge in medicine and healthcare by improving awareness and understanding in the medical community. We will consider grant requests focused on our therapeutic areas of interest.
Agios is committed to developing innovative treatment options that make a meaningful difference in patients’ lives and fundamentally change the way genetically defined diseases are treated. Learn more about our ongoing trials, including studies that are currently recruiting.
Check out our list of vetted Agios and third-party resources for patients and caregivers.